Q₁₀uest for New Therapies to Prevent Antiphospholipid Antibody-Mediated Thrombosis

Affiliations

¹ From the Department of Medicine, McAllister Heart Institute (S.P.G.) and Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center (R.A.S.R.), The University of North Carolina at Chapel Hill.
² From the Department of Medicine, McAllister Heart Institute (S.P.G.) and Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center (R.A.S.R.), The University of North Carolina at Chapel Hill. robert_roubey@med.unc.edu.

Editorial

Steven P Grover et al. Arterioscler Thromb Vasc Biol. 2017 Oct.

. 2017 Oct;37(10):1801-1802.

doi: 10.1161/ATVBAHA.117.309955.

¹ From the Department of Medicine, McAllister Heart Institute (S.P.G.) and Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center (R.A.S.R.), The University of North Carolina at Chapel Hill.
² From the Department of Medicine, McAllister Heart Institute (S.P.G.) and Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center (R.A.S.R.), The University of North Carolina at Chapel Hill. robert_roubey@med.unc.edu.

No abstract available

Keywords: Editorials; antiphospholipid; oxidative stress; thrombosis; tissue factor.

Comment on

The pathogenesis of the antiphospholipid syndrome.
Giannakopoulos B, Krilis SA. Giannakopoulos B, et al. N Engl J Med. 2013 Mar 14;368(11):1033-44. doi: 10.1056/NEJMra1112830. N Engl J Med. 2013. PMID: 23484830 Review. No abstract available.